Type 2 Diabetes and Dementia

Produk Detail:
  • Author : Velandai Srikanth
  • Publisher : Academic Press
  • Pages : 320 pages
  • ISBN : 0128096942
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Type 2 Diabetes and Dementia

Download or Read online Type 2 Diabetes and Dementia full in PDF, ePub and kindle. this book written by Velandai Srikanth and published by Academic Press which was released on 09 February 2018 with total page 320 pages. We cannot guarantee that Type 2 Diabetes and Dementia book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology. Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinology Includes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications

Type 2 Diabetes and Dementia

Type 2 Diabetes and Dementia
  • Author : Velandai Srikanth,Zoe Arvanitakis
  • Publisher : Academic Press
  • Release : 09 February 2018
GET THIS BOOK Type 2 Diabetes and Dementia

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of

The interaction of type 2 diabetes type 3 diabetes Alzheimer s disease and the gut microbiota

The interaction of type 2 diabetes  type 3 diabetes  Alzheimer s disease   and the gut microbiota
  • Author : Hyder Mirghani
  • Publisher : GRIN Verlag
  • Release : 19 December 2017
GET THIS BOOK The interaction of type 2 diabetes type 3 diabetes Alzheimer s disease and the gut microbiota

Literature Review from the year 2017 in the subject Medicine - Internal Medicine, grade: C, , language: English, abstract: Dementia is a multifaceted syndrome with a significant public health, social, and economic burden; there are forty-four million people affected by the disease worldwide according to the most recent estimate.The number is projected to double by the year 2030 and to triple by 2050. Alzheimer's disease (AD, or type-3 diabetes mellitus) and vascular dementia are the most common forms of dementia. Lifestyle risk factors

The Interaction of Type 2 Diabetes Type 3 Diabetes Alzheimer s Disease and Thegut Microbiota

The Interaction of Type 2 Diabetes  Type 3 Diabetes  Alzheimer s Disease   and Thegut Microbiota
  • Author : Hyder Mirghani
  • Publisher : Grin Publishing
  • Release : 12 January 2018
GET THIS BOOK The Interaction of Type 2 Diabetes Type 3 Diabetes Alzheimer s Disease and Thegut Microbiota

Literature Review from the year 2017 in the subject Medicine - Internal Medicine, grade: C, language: English, abstract: Dementia is a multifaceted syndrome with a significant public health, social, and economic burden; there are forty-four million people affected by the disease worldwide according to the most recent estimate.The number is projected to double by the year 2030 and to triple by 2050. Alzheimer's disease (AD, or type-3 diabetes mellitus) and vascular dementia are the most common forms of dementia. Lifestyle risk factors

A Study of Mechanisms Linking Type 2 Diabetes Mellitus and Dementia

A Study of Mechanisms Linking Type 2 Diabetes Mellitus and Dementia
  • Author : Christopher Moran
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK A Study of Mechanisms Linking Type 2 Diabetes Mellitus and Dementia

Background: Dementia is highly prevalent in older age, accounts for a significant proportion of age-related disability, and is one of the most expensive disorders affecting older Australians. T2DM affects about 85% of all people with diabetes and occurs more commonly in older age. T2DM increases the risk of vascular dementia and Alzheimer's dementia (AD) although there may be substantial overlap of the two pathologies. The underlying pathways between T2DM and dementia may involve neurodegeneration, vascular disease, or both,

The New Threat of Type 3 Diabetes

The New Threat of Type 3 Diabetes
  • Author : Alan D. Raguso,Maria Lizotte RN BSN CDE
  • Publisher : iUniverse
  • Release : 08 November 2018
GET THIS BOOK The New Threat of Type 3 Diabetes

The American diet is typically high in sugar consumption and extremely acidic. This lifestyle leads to insulin resistance, inflammation, diabetes, high blood pressure, risk for heart attack or stroke, and possibly dementia and Alzheimer’s disease. In The New Threat of Type 3 Diabetes, authors Alan D. Raguso and Maria Lizotte offer an understanding of diabetes, discussing why people’s health declines and why they get sick. Based on their personal and professional experiences with diabetes, they discuss concepts of body

The Diabetic Brain in Alzheimer s Disease How Insulin Resistance in Type 2 Diabetes and Type 3 Diabetes Triggers Your Risk for Alzheimer s and How

The Diabetic Brain in Alzheimer s Disease  How Insulin Resistance in Type 2 Diabetes and  Type 3 Diabetes  Triggers Your Risk for Alzheimer s and How
  • Author : Ralph Sanchez Mtcm
  • Publisher : Braindefend LLC
  • Release : 21 August 2019
GET THIS BOOK The Diabetic Brain in Alzheimer s Disease How Insulin Resistance in Type 2 Diabetes and Type 3 Diabetes Triggers Your Risk for Alzheimer s and How

The thought of living out one's life with dementia conjures up a helpless and foreboding feeling. What if it happens to me?Can I do anything to prevent it?One in ten people age 65 and older has Alzheimer's, and the prevalence of the disease jumps to three in ten after the age of 85. One in three seniors will die from Alzheimer's or another form of dementia according to the Alzheimer's Association. The financial burden for top level care can be

Diabetes and the Brain

Diabetes and the Brain
  • Author : Geert Jan Biessels,Jose A. Luchsinger
  • Publisher : Springer Science & Business Media
  • Release : 18 September 2009
GET THIS BOOK Diabetes and the Brain

Diabetes, particularly type 2, has become increasingly more common around the world. Consequently, the effect of diabetes on the brain has achieved enormous public health importance. A surge in pre-clinical and clinical research on topics ranging from management of hyperglycemia in acute stroke to disturbances in insulin signaling in Alzheimer’s disease has led to substantial progress in the field. Written by a panel of international experts, Diabetes and the Brain provides in depth reviews on the cerebral complications of diabetes,

Depression and Type 2 Diabetes

Depression and Type 2 Diabetes
  • Author : Khalida Ismail,Andreas Barthel,Stefan R. Bornstein,Julio Licinio
  • Publisher : Oxford University Press
  • Release : 23 August 2018
GET THIS BOOK Depression and Type 2 Diabetes

Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are

The New Threat of Type 3 Diabetes

The New Threat of Type 3 Diabetes
  • Author : Alan D. Raguso,Maria Lizotte Rn Bsn Cde
  • Publisher : Unknown
  • Release : 08 November 2018
GET THIS BOOK The New Threat of Type 3 Diabetes

The American diet is typically high in sugar consumption and extremely acidic. This lifestyle leads to insulin resistance, inflammation, diabetes, high blood pressure, risk for heart attack or stroke, and possibly dementia and Alzheimer's disease. In The New Threat of Type 3 Diabetes, authors Alan D. Raguso and Maria Lizotte offer an understanding of diabetes, discussing why people's health declines and why they get sick. Based on their personal and professional experiences with diabetes, they discuss concepts of body chemistry, look

Diabetes Mellitus

Diabetes Mellitus
  • Author : Yusaku Nakabeppu,Toshiharu Ninomiya
  • Publisher : Springer
  • Release : 06 May 2019
GET THIS BOOK Diabetes Mellitus

This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore

Diet and Nutrition in Dementia and Cognitive Decline

Diet and Nutrition in Dementia and Cognitive Decline
  • Author : Colin R. Martin,Victor R. Preedy
  • Publisher : Academic Press
  • Release : 30 December 2014
GET THIS BOOK Diet and Nutrition in Dementia and Cognitive Decline

Diet and Nutrition in Dementia and Cognitive Decline offers researchers and clinicians a single authoritative source which outlines the complex interrelationships between cognitive decline, dementia and the way diet can be modified to improve outcomes. In a cross-disciplinary field like dementia research and practice, clinicians and researchers need a comprehensive resource which will quickly help them identify a range of nutritional components and how they affect cognitive decline and the development of dementia. While the focus is on clinical applications,

Diabetes and Aging An Issue of Clinics in Geriatric Medicine

Diabetes and Aging  An Issue of Clinics in Geriatric Medicine
  • Author : Elsa S. Strotmeyer
  • Publisher : Elsevier Health Sciences
  • Release : 26 December 2014
GET THIS BOOK Diabetes and Aging An Issue of Clinics in Geriatric Medicine

This issue of Clinics in Geriatric Medicine, guest edited by Dr. Elsa S. Strotmeyer, is devoted to Medical Complications of Diabetes in Older Adults. Articles in this issue include: Glucose Dysregulation: Pathophysiology and Prevention; Diabetic Medications and Polypharmacy; Physical Function and Disability; Diabetes and Osteoarthritis; Adiposity, Muscle Mass, and Diabetes; Exercise and Weight Loss in Diabetes Management; Diabetes and Cognition; Diabetes and Depression; Sleep Apnea and Diabetes; Diabetes and Coronary Artery Disease; and Diabetes and Balance and Falls.

Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Dementia in Patients with Type 2 Diabetes and Hypertension

Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Dementia in Patients with Type 2 Diabetes and Hypertension
  • Author : Hemalkumar B. Mehta
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Dementia in Patients with Type 2 Diabetes and Hypertension

Objectives: Specific aims of the study were: (1) To develop RxDx risk index to predict dementia in patients with type 2 diabetes mellitus and hypertension (2) To compare RxDx risk index with different versions of Charlson comorbidity score (CCS) and chronic disease score (CDS) to predict dementia and (3) To compare Angiotensin Converting Enzyme (ACE) inhibitors versus Angiotensin Receptor Blockers (ARB) for the risk of dementia in patients with type 2 diabetes mellitus and hypertension. Methods: The Clinical Practice Research database was used for this